INSM

Insmed Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 0/10
  • Value 0/10
Insmed sales and earnings growth
INSM Growth
Low
  • Revenue Y/Y 80.61%
  • EPS Y/Y 3.20%
  • FCF Y/Y -16.77%
Insmed gross and profit margin trends
INSM Profitability
Good
  • Gross margin 81.80%
  • EPS margin -144.40%
  • ROIC 5Y -47.68%
Insmed net debt vs free cash flow
INSM Risk
Good
  • Debt / Equity 1.1
  • Debt / FCF 0.2
  • Interest coverage -13.3

Insmed stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Biotechnology stocks